Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
April 1, 2025
Saampras Ganesan, Fernando A Barrios, Ishaan Batta et al.
6 citations
Meditation is a family of ancient and contemporary contemplative mind-body practices that can modulate psychological processes, awareness, and mental states. Over the last 40 years, clinical science has manualized meditation practices and designed various meditation interventions that have shown therapeutic efficacy for disorders including depression, pain, addiction, and anxiety. Over the past...
Journal of Consulting and Clinical Psychology
April 1, 2025
Judy Garber, Denise A Chavira, Emma K Adam et al.
5 citations
The purpose of this randomized controlled trial was to test the effects of an online, coached mindfulness intervention on momentary negative affect (mNA) for youth with high levels of trait negative affectivity. Participants were 111 youth ages 12 to 17 years old (M = 14.17, SD = 1.60). Youth self-identified as 68% female, 29% male, and 4.5% gender diverse; 54.55% identified as White; 31.82...
Journal of Religion and Health
April 1, 2025
Thomas G. Plante, David B. Feldman, Jacqueline Ge et al.
6 citations
This is a randomized controlled trial of an Examen-based practice, an intervention reflecting a five-step daily reflection and prayer practice developed by St. Ignatius of Loyola, founder of the Catholic Jesuit order. Like other practices (e.g., mindfulness, yoga), this practice can be used as a spiritual or secular intervention to help people with a variety of challenges and stressors. In this...
Hu li za zhi The journal of nursing
April 1, 2025
Chun-Yu Lin
Mindfulness and compassion have gained increasing recognition in global healthcare and nursing fields in recent years as important strategies for enhancing the mental health of healthcare professionals, reducing their occupational burnout, and improving the quality of clinical care they provide. In this article, the historical development, mechanisms, and applications of mindfulness in...
PLOS digital health
April 1, 2025
Abhishek Aggarwal, Shan Qiao, Chih-Hsiang Yang et al.
1 citation
COVID-19 long haulers face profound psychosocial stressors (e.g., depression, anxiety, PTSD) and physical health challenges (e.g., brain fog, fatigue). This study tests the feasibility and initial impact of a digitally delivered mindful-walking (MW) intervention for improving the physical and psychosocial wellbeing of COVID-19 long haulers. We recruited 23 participants via Facebook groups,...
BMJ Open
April 1, 2025
Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum et al.
2 citations
Introduction Prolonged grief disorder (PGD) represents a substantial public health issue, especially in oncology settings where it affects up to 30% of bereaved carers. Current best-practice treatments are lengthy, and up to 50% of participants have persistent PGD. Building on encouraging recent research with psychedelic-assisted therapies, the Psilocybin-Assisted suppoRtive psychoTherapy IN...
Asian Journal of Psychiatry
April 1, 2025
Asif Seraj, Mohammed Reyazuddin, R K Gaur et al.
11 citations
The simplest, most convenient, and least expensive way to treat depressed and suicidal patients with ketamine is to administer racemic ketamine by the oral route. We describe the first active-controlled randomized clinical trial of oral racemic ketamine for suicidal ideation associated with depression. Adult patients with major depressive disorder and expressed suicidal ideation were randomized...
Journal of Psychiatric Research
April 1, 2025
Kristian Elersič, Anamarija Banjac, Marko Živin et al.
3 citations
Ketamine, a fast-acting antidepressant, is a racemic mixture, composed of equal amounts of R- and S-ketamine. Preclinical studies are comparing them to better understand their role in therapeutic and undesirable effects. An important research gap is that studies do not use long clinically relevant protocols to compare the desired and undesired effects of ketamine enantiomers in modeled and...
Schizophrenia Research
April 1, 2025
Sofia de Almeida Queiroz, Linério Ribeiro de Novais Junior, Anita Beatriz Pacheco de Carvalho et al.
2 citations
Schizophrenia (SCZ) has limited treatment options, often with significant side effects. Cannabidiol (CBD), a non-euphoric phytocannabinoid, has shown potential as a novel therapeutic option in SCZ due to antipsychotic-like, anti-inflammatory, and antioxidant properties. We compared the therapeutic effects of CBD and risperidone (RISP) in a rat model of SCZ induced by sub-chronic ketamine (KET),...
Journal of clinical anesthesia
April 1, 2025
Qingfeng Wei, Mengmeng Li, Qiuling Du et al.
10 citations
To determine whether intraoperative low-dose esketamine ameliorates depression in women having breast cancer surgery. A prospective single-center double blind randomized placebo-controlled trial. Perioperative period, operating room, post anesthesia care unit and hospital ward. 108 women 18-65 years old who were scheduled for elective breast cancer surgery. All had preoperative depressive...